Cancer Immunology, Immunotherapy Issues Research Articles in February 2023 Edition
January 24, 2023
January 24, 2023
BASEL, Switzerland, Jan. 24 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles, including the following topics, in its February 2023 edition:
Original Articles:
* Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
* Personalized tumor vaccine for pancreatic cance . . .
Original Articles:
* Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
* Personalized tumor vaccine for pancreatic cance . . .